These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5150095)
1. [Intoxications by butyrophenones]. Gaultier M; Fahti D Eur J Toxicol; 1971; 4(5):385-402. PubMed ID: 5150095 [No Abstract] [Full Text] [Related]
2. [Central and peripheral secondary effects of some butyrophenones]. Salvini L; Frosali L; Gigli M Minerva Anestesiol; 1969 Apr; 35(4):334-44. PubMed ID: 5789993 [No Abstract] [Full Text] [Related]
3. Pharmacology of three mammotropic butyrophenones in the rat. Givant Y; Shani J; Goldhaber G; Serebrenik R; Sulman FG Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):317-27. PubMed ID: 4797373 [No Abstract] [Full Text] [Related]
4. Circadian rhythms during drug-induced coma. (Transverse study of rectal temperature, heart rate, systolic blood pressure, urinary water and potassium). Reinberg A; Gervais P; Pollak E; Abulker C; Dupont J Int J Chronobiol; 1973; 1(2):157-62. PubMed ID: 4149338 [No Abstract] [Full Text] [Related]
5. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity. Janssen PA; Allewijn FT Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759 [No Abstract] [Full Text] [Related]
6. [Radioprotective properties of butyrophenone derivatives]. Uray Z; Farcasanu M; Maniu M Agressologie; 1970; 11(4):357-60. PubMed ID: 5485665 [No Abstract] [Full Text] [Related]
7. Central and peripheral autonomic integrity in Parkinson's disease. Adhiyaman V; Hobson P; Meara RJ Age Ageing; 2008 Sep; 37(5):578-81. PubMed ID: 18687873 [No Abstract] [Full Text] [Related]
9. [Neurologic manifestations of hyponatremias]. Goulon M; Babinet P; Raphaël JC; Grosbuis S; Gajdos P Rev Neurol (Paris); 1971 Sep; 125(3):219-37. PubMed ID: 5152002 [No Abstract] [Full Text] [Related]
10. Results of trifluperidol therapy. Szobor A Ther Hung; 1969; 17(3):109-14. PubMed ID: 5356925 [No Abstract] [Full Text] [Related]
11. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [TBL] [Abstract][Full Text] [Related]
13. [Comparison between neuroleptanalgesia with levomepromazine-pethidine and that with dehydro-benzperidol-fentanyl]. Litarczek G; Fagarasanu R; Petrilra T; Darutzi A Anesth Analg (Paris); 1969; 26(6):857-69. PubMed ID: 5378673 [No Abstract] [Full Text] [Related]
14. Involvement of the nervous system in malaria in Thailand. Chipman M; Cadigan FC; Benjapongse W Trop Geogr Med; 1967 Mar; 19(1):8-14. PubMed ID: 6040659 [No Abstract] [Full Text] [Related]
15. Clinical features of ciguatera fish poisoning: a study of the disease in the US Virgin Islands. Morris JG; Lewin P; Hargrett NT; Smith CW; Blake PA; Schneider R Arch Intern Med; 1982 Jun; 142(6):1090-2. PubMed ID: 7201299 [TBL] [Abstract][Full Text] [Related]
16. [Acute hypotensive effect of a central dopaminergic agonist, piribedil, administered intravenously in the normotensive human]. Ziegler M; Georgiadis G; Elghozi JL Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1186-90. PubMed ID: 6441537 [TBL] [Abstract][Full Text] [Related]